EUVIMEDEUVIMED entdecken
Validierungsstudie

Peritoneal lavage fluid minimal residual cancer cells detection for early prediction of peritoneal metastasis in gastric cancer: A multi‐cohort validation study

Pinli Yue, Zhendiao Zhou, Zefeng Li, Chunxia Du, Liping Jiang, Liting Yang, Yuchen Jiao iD, Dongbing Zhao iD

International Journal of Cancer · 01.06.2026 · 158 (11) · 3007-3020

DOI: 10.1002/ijc.70233 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Journal of Cancer, online erschienen am 14.11.2025. Verfasst von Pinli Yue und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of M…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Peritoneal Neoplasms, Neoplasm, Residual, Ascitic Fluid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation Fund, the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peritoneal metastasis (PM) remains a major cause of mortality in gastric cancer, yet current diagnostic methods lack sensitivity for early detection. This study aimed to validate the clinical value of minimal residual cancer cells detection in peritoneal lavage fluid (PLF) for predicting and monitoring PM. This study extended follow‐up analysis of a previously reported exploratory cohort ( n = 104) and validated findings in a new validation cohort ( n = 76). Using personalized mutation profiling, we detected cancer cell fraction (CCF) in pre‐resection PLF, post‐resection PLF, and circulating tumor DNA (ctDNA) in matched blood samples. Additionally, we monitored CCF and ctDNA dynamics in five patients receiving intraperitoneal chemotherapy (IPC). In the combined cohort ( n = 180), pre‐resection PLF CCF status showed 98% sensitivity and 80% specificity for PM prediction, while post‐resection PLF demonstrated 82% sensitivity and 90% specificity. Combining pre‐ and post‐resection PLF analysis achieved 100% sensitivity with 80% specificity. Compared to PLF cytology and plasma ctDNA, PLF CCF status emerged as the strongest independent predictor of PM (HR = 177.78, 95% CI: 23.14–22,968.19, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsPeritoneal NeoplasmsNeoplasm, ResidualAscitic FluidHumansFemaleMaleMiddle AgedPeritoneal LavageAgedCirculating Tumor DNACohort StudiesBiomarkers, TumorPrognosisAdultFollow-Up Studies

Stichwörter der Autor:innen

cancer cell fractioncirculating tumor DNAgastric cancerintraperitoneal chemotherapyperitoneal metastasis

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Center of Laboratory Medicine, State Key Laboratory of Cardiovascular Disease, Beijing Key Laboratory for Molecular Diagnostics of Cardiovascular Diseases, Diagnostic Laboratory Service, Fuwai Hospital, National Center…
  • Department of Pancreatic and Gastric Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing,…
  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Institute of Cancer Research, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.

ORCID-Profile: Yuchen Jiao, Dongbing Zhao

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation Fund
  • the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences
  • Shenzhen Medical Research Fund
  • the Beijing Hope Run Special Fund of Cancer Foundation of China

Zitieren

APA

Yue, P., Zhou, Z., Li, Z., Du, C., Jiang, L., Yang, L., Jiao, Y., & Zhao, D. (2026). Peritoneal lavage fluid minimal residual cancer cells detection for early prediction of peritoneal metastasis in gastric cancer: A multi‐cohort validation study. International Journal of Cancer, 158(11), 3007-3020. https://doi.org/10.1002/ijc.70233

Vancouver

Yue P, Zhou Z, Li Z, Du C, Jiang L, Yang L, et al. Peritoneal lavage fluid minimal residual cancer cells detection for early prediction of peritoneal metastasis in gastric cancer: A multi‐cohort validation study. International Journal of Cancer. 2026;158(11):3007-3020. doi:10.1002/ijc.70233

BibTeX
@article{Yue2026,
  author = {Yue, Pinli and Zhou, Zhendiao and Li, Zefeng and Du, Chunxia and Jiang, Liping and Yang, Liting and Jiao, Yuchen and Zhao, Dongbing},
  title = {Peritoneal lavage fluid minimal residual cancer cells detection for early prediction of peritoneal metastasis in gastric cancer: A multi‐cohort validation study},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {158},
  number = {11},
  pages = {3007--3020},
  doi = {10.1002/ijc.70233}
}
Kostenlos starten →